Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
291
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Wuxi Biologics
•
21 Jun 2023 08:55
Wuxi Biologics (2269.HK) - Investor Day Brings New Surprises
The information WuXi Bio disclosed on Investor Day was disappointing, leading to share price plunge.2023's growth is worrying. It's too early to...
Xinyao (Criss) Wang
Follow
404 Views
Share
bullish
•
SK Pharmteco
•
17 May 2023 17:11
SK Pharmteco Pre-IPO Funding & Impact on SK Inc
SK Pharmteco is seeking valuation of about 5 trillion won which is much higher than its book value of 1.65 trillion won. SK Pharmteco (100% owned...
Douglas Kim
Follow
331 Views
Share
bullish
•
Samsung Biologics
•
27 Apr 2023 18:14
Samsung Biologics (207940 KS): Slow Start of 2023; Stronger Growth in H2; 2023 Guidance Raised
Samsung Biologics reported net profit decline of 4% YoY in Q1 due to a one-off factor. Anticipating a stronger H2, the company has raised 2023...
Tina Banerjee
Follow
281 Views
Share
bearish
•
Ecopro Co Ltd
•
19 Apr 2023 01:39
Korean Holdcos Vs Opcos Gap Trading Opportunities in 2Q 2023
In this insight, we highlight the pricing gap divergences of the major Korean holdcos and opcos in 2Q 2023. We highlight 38 pair trades that...
Douglas Kim
Follow
416 Views
Share
bullish
•
Samsung SDI
•
15 Apr 2023 15:34
Price/Flow Impact on Four Constituent Changes in KODEX Top 5 Plus ETF Rebalancing in June
This post presents a Long Short basket trade idea on the four potential constituent changes in the KODEX Top 5 Plus TR ETF rebalancing in June.
Sanghyun Park
Follow
498 Views
Share
First
Previous
7
8
9
10
11
12
13
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x